Devonian Health Group Inc. (DVHGF)
DVHGF Stock Price Chart
Explore Devonian Health Group Inc. interactive price chart. Choose custom timeframes to analyze DVHGF price movements and trends.
DVHGF Company Profile
Discover essential business fundamentals and corporate details for Devonian Health Group Inc. (DVHGF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
19 Sept 2022
Employees
6.00
Website
https://groupedevonian.comCEO
Luc D. Gregoire CA, CPA
Description
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine, a Phase IIa clinical trial product for the treatment of ulcerative colitis and atopic dermatitis. The company also develops Pantoprazole Magnesium for the treatment of gastric or duodenal ulcers; Cleo-35 for the treatment of hormonal acne in women; and value-added products for dermo-cosmetics. In addition, it acquires drug and health product licenses; and distributes pharmaceutical products. Devonian Health Group Inc. has a strategic alliance with CannTx Life Sciences Inc. for the development of cannabinoid-based pharmaceutical drugs. The company was incorporated in 2015 and is headquartered in Québec, Canada.
DVHGF Financial Timeline
Browse a chronological timeline of Devonian Health Group Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 9 Apr 2026
Upcoming earnings on 22 Dec 2025
Earnings released on 26 Jun 2025
EPS came in at -$0.02 , while revenue for the quarter reached $5.33M .
Earnings released on 15 Apr 2025
EPS came in at -$0.00 , while revenue for the quarter reached $5.99M .
Earnings released on 20 Dec 2024
EPS came in at -$0.00 , while revenue for the quarter reached $4.20M .
Earnings released on 29 Nov 2024
EPS came in at $0.01 , while revenue for the quarter reached $6.59M .
Earnings released on 25 Jun 2024
EPS came in at -$0.00 , while revenue for the quarter reached $3.75M .
Earnings released on 27 Mar 2024
EPS came in at -$0.01 , while revenue for the quarter reached $1.69M .
Earnings released on 22 Dec 2023
EPS came in at -$0.00 , while revenue for the quarter reached $924.34K .
Earnings released on 28 Nov 2023
EPS came in at -$0.00 , while revenue for the quarter reached $806.06K .
Earnings released on 30 Jun 2023
EPS came in at -$0.01 , while revenue for the quarter reached $339.10K .
Earnings released on 30 Apr 2023
EPS came in at -$0.01 , while revenue for the quarter reached $298.68K .
Earnings released on 22 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $476.99K .
Earnings released on 31 Oct 2022
EPS came in at -$0.01 , while revenue for the quarter reached $300.85K .
Earnings released on 30 Apr 2022
EPS came in at -$0.00 , while revenue for the quarter reached $568.10K .
Earnings released on 31 Jan 2022
EPS came in at -$0.01 , while revenue for the quarter reached $412.33K .
Earnings released on 31 Oct 2021
EPS came in at -$0.01 , while revenue for the quarter reached $356.02K .
Earnings released on 31 Jul 2021
EPS came in at -$0.01 , while revenue for the quarter reached $267.67K .
Earnings released on 30 Apr 2021
EPS came in at -$0.01 , while revenue for the quarter reached $207.20K .
Earnings released on 31 Jan 2021
EPS came in at -$0.01 , while revenue for the quarter reached $267.86K .
Earnings released on 31 Oct 2020
EPS came in at -$0.01 , while revenue for the quarter reached $407.88K .
DVHGF Stock Performance
Access detailed DVHGF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.